Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors
CA 2533763 C · Owner: Wilson, Mark E. · Inventors: Kafka, Mark D.; Lopaschuk, Gary D.; Russell, Anna
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods for the use of compounds as depicted by structure (I), pharmaceutical compositions containing the same and methods , for the prophylaxis, management and treatment of metabolic diseases and diseases modulated by MCD inhibition. The compounds disclosed in this invention are useful for the prophylaxis management and treatment of diseases , involving in malonyl-CoA regulated glucose/fatty acid metabolism pathway. In particular, these compounds and pharmaceutical composition containing the same are indicated in the prophylaxis, management and treatment of cardiovascular diseases, diabetes, cancer and obesity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 28, 2004 and granted November 20, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 28, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 28, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.